News Release

Why failing hearts have trouble handling succinate

Researchers uncover a stress-driven defect in succinate metabolism and show that empagliflozin can restore this disrupted step in mice

Peer-Reviewed Publication

Science China Press

Succinate accumulation in heart failure: finding the cause, restoring succinate balance

image: 

Why does succinate accumulate in the failing heart? Researchers found that stress triggers a series of protein changes that slows its processing. In mice, empagliflozin helped restore this step, reducing succinate accumulation and improving heart function.

view more 

Credit: ©Science China Press

Succinate is a molecule normally produced and used as cells generate energy. In a healthy heart, it moves through the tricarboxylic acid cycle, a series of reactions that helps turn nutrients into usable energy. But when succinate accumulates, it can also send signals that promote inflammation and tissue injury.

Elevated succinate has been reported in heart failure and several other inflammatory and metabolic diseases. Its accumulation may therefore do more than signal that something is wrong with metabolism. It may also contribute to further damage. What has been less clear is why succinate accumulates in the failing heart.

The team examined blood samples from 308 patients and 63 healthy controls. Higher succinate levels were associated with poorer heart function, prompting the researchers to investigate what was causing the accumulation.

They traced it to a series of protein changes triggered by cardiac stress. Stress increases the activity of SYVN1, a protein that tags other proteins for removal. SYVN1 speeds up the breakdown of NRF1, which helps maintain the production of SDHB. SDHB is a key part of the enzyme that converts succinate into the next molecule in the cycle. With less SDHB available, this step slows down and succinate begins to accumulate.

These events offers an explanation for how sustained cardiac stress leads to succinate accumulation. It also points to a specific step that treatment might help restore.

In mice with heart failure, empagliflozin helped restore SDHB and get succinate metabolism moving again. Succinate accumulation fell, and heart function improved. The findings suggest that restoring this disrupted step may contribute to the drug’s protective effects.

 

Publication information

Hongtu Cui, Lu Fang, Huanhuan Cao, Rui Zhan, Yawen Deng, Mingming Zhao, Xin Guo, Haiyi Yu, Wenli Xu, Yanbo Xue, Sen Huang, Xiaoyi Liu, Zeshan Zhang, Wei Gao, Youyi Zhang, Erdan Dong, Lemin Zheng, and Han Xiao. 2026. SYVN1-mediated succinate accumulation exacerbates heart failure. SCIENCE CHINA Life Sciences.

DOI: 10.1007/s11427-026-3389-1


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.